Liver cancer cases and deaths projected to rise by more than 55% by 2040

by ElsevierMain findings on the global burden of liver cancer in 2020 and predictions to 2040. Credit:Journal of HepatologyA new analysis reveals that primary liver cancer was among t

Updated on: February 18,2024

Liver cancer cases and deaths projected to rise by more than 55% by 2040

by ElsevierMain findings on the global burden of liver cancer in 2020 and predictions to 2040. Credit:Journal of HepatologyA new analysis reveals that primary liver cancer was among t

Updated on:February 18,2024

Study uncovers unknown interaction between leukemic cells and immune cells

by Karl Landsteiner University of Health SciencesAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainThe protein STAT3 helps the immune system to recognize leukemic cells. This interact

Updated on: July 17,2024

Study uncovers unknown interaction between leukemic cells and immune cells

by Karl Landsteiner University of Health SciencesAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainThe protein STAT3 helps the immune system to recognize leukemic cells. This interact

Updated on:July 17,2024

The right moves: How studying cell movement during embryonic development may offer new insights into cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterUnder the microscope, MSK scientists studied how cells in a mouse embryo (green) move out and break away from their original tissue by contrac

Updated on: February 23,2024

The right moves: How studying cell movement during embryonic development may offer new insights into cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterUnder the microscope, MSK scientists studied how cells in a mouse embryo (green) move out and break away from their original tissue by contrac

Updated on:February 23,2024

Device might detect breast cancer-linked swelling sooner

by Maureen Salamon, Healthday Reporter(HealthDay)—Testing for small changes in the flow of lymph fluids after breast cancer surgery can spot the start of a painful swelling known as lymphedema before

Updated on: April 14,2024

Device might detect breast cancer-linked swelling sooner

by Maureen Salamon, Healthday Reporter(HealthDay)—Testing for small changes in the flow of lymph fluids after breast cancer surgery can spot the start of a painful swelling known as lymphedema before

Updated on:April 14,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on: June 01,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on:June 01,2024

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Updated on: May 17,2024

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Updated on:May 17,2024

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on: March 24,2024

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on:March 24,2024

Researchers demonstrate technique for identifying single cancer cells in blood for the first time

byKeele UniversityBrightfield image of a cytospun sample containing PBMC and individual CALU-1 cancer cells. Credit:PLOS ONE(2023). DOI: 10.1371/journal.pone.0289824A pioneering stud

Updated on: March 30,2024

Researchers demonstrate technique for identifying single cancer cells in blood for the first time

byKeele UniversityBrightfield image of a cytospun sample containing PBMC and individual CALU-1 cancer cells. Credit:PLOS ONE(2023). DOI: 10.1371/journal.pone.0289824A pioneering stud

Updated on:March 30,2024

132-pound tumor removed from woman's abdomen

In this February 2018 photograph provided by the Danbury Hospital, a large tumor is prepared to be removed from a patient at the hospital in Danbury, Conn. Doctors removed the 132-pound tumor from a w

Updated on: March 08,2024

132-pound tumor removed from woman's abdomen

In this February 2018 photograph provided by the Danbury Hospital, a large tumor is prepared to be removed from a patient at the hospital in Danbury, Conn. Doctors removed the 132-pound tumor from a w

Updated on:March 08,2024

A new natural killer cell therapy product with promising anticancer effects

by DGIST (Daegu Gyeongbuk Institute of Science and Technology)Schematic diagram of the MBP technology in NK cells and expected role in the tumor site. (A) Schematic illustration of cytokine engineered

Updated on: February 03,2024

A new natural killer cell therapy product with promising anticancer effects

by DGIST (Daegu Gyeongbuk Institute of Science and Technology)Schematic diagram of the MBP technology in NK cells and expected role in the tumor site. (A) Schematic illustration of cytokine engineered

Updated on:February 03,2024

Researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy

byCleveland ClinicNeoantigen screening design and genomic features of NSCLC cohort.a, WES was performed onn= 58 pre-therapy samples andn= 42 on-therapy samples, whi

Updated on: November 10,2024

Researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy

byCleveland ClinicNeoantigen screening design and genomic features of NSCLC cohort.a, WES was performed onn= 58 pre-therapy samples andn= 42 on-therapy samples, whi

Updated on:November 10,2024

Hereditary colorectal cancer: Researchers reclassify a large proportion of leading gene variants as benign

by Inka Väth,University Hospital of BonnGraphical abstract. Credit:The American Journal of Human Genetics(2024). DOI: 10.1016/j.ajhg.2024.09.002The genetic confirmation of a suspecte

Updated on: November 10,2024

Hereditary colorectal cancer: Researchers reclassify a large proportion of leading gene variants as benign

by Inka Väth,University Hospital of BonnGraphical abstract. Credit:The American Journal of Human Genetics(2024). DOI: 10.1016/j.ajhg.2024.09.002The genetic confirmation of a suspecte

Updated on:November 10,2024